5.64
+0.6149(+12.22%)
Currency In USD
| Previous Close | 5.03 |
| Open | 5.19 |
| Day High | 5.69 |
| Day Low | 5.12 |
| 52-Week High | 7.3 |
| 52-Week Low | 1.26 |
| Volume | 3.34M |
| Average Volume | 5.43M |
| Market Cap | 1.34B |
| PE | -5.33 |
| EPS | -1.06 |
| Moving Average 50 Days | 3.55 |
| Moving Average 200 Days | 2.93 |
| Change | 0.61 |
If you invested $1000 in Sana Biotechnology, Inc. (SANA) since IPO date, it would be worth $160.82 as of October 20, 2025 at a share price of $5.645. Whereas If you bought $1000 worth of Sana Biotechnology, Inc. (SANA) shares 3 years ago, it would be worth $1,077.27 as of October 20, 2025 at a share price of $5.645.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sana Biotechnology to Present at September 2025 Investor Conferences
GlobeNewswire Inc.
Aug 26, 2025 8:05 PM GMT
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conference
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire Inc.
Aug 20, 2025 8:05 PM GMT
SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its co
Sana Biotechnology Announces Pricing of Public Offering
GlobeNewswire Inc.
Aug 07, 2025 3:24 AM GMT
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering of 20